Evaluation of Serum Amyloid A3 in Young Adult Males with Early Onset of Androgenic Alopecia

The study evaluated Serum Amyloid A3 (SAA3) levels in young adult males with early-onset androgenetic alopecia (AGA) and explored the relationship between SAA3 levels and atherosclerosis. Conducted at Benha University from January to June 2019, the cross-sectional study included patients from the Dermatology, Venerology, and Andrology Department. Results indicated that patients under 30 years old with grade III and IV AGA, especially those with a family history of heart disease and elevated lipid profiles, had significantly higher SAA3 levels. This group was at a higher risk of developing arterial atherosclerotic disease compared to peers without AGA.